Drug
Idronoxil Suppository NOX66 clinical trials
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2017
How studies write it
Studies that test it under each name
Written with another drug
- NOX66
- 5
Studies by the year they started
6 studies that test it; most in 2017 (2)
| Year | Studies |
|---|---|
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 0
Noxopharm Limited (6)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Idronoxil Suppository NOX66 is read from its arms, and is right about nine times in ten.
Testing it · 6
- Safety and Tolerability of NOX66 in Combination With Palliative Radiotherapy in Patients With Late-Stage Prostate CancerCompletedPhase 1Noxopharm LimitedNCT03307629Written as NOX66
- A Study of NOX66 Plus Doxorubicin in Anthracycline-naïve, Adult Patients With Soft Tissue SarcomaTerminatedPhase 1Noxopharm LimitedNCT05100628Written as NOX66
- A Study of NOX66 and External Beam Radiotherapy in Patients With Metastatic Castration-resistant Prostate Cancer and Other Solid TumorsTerminatedPhase 1/2Noxopharm LimitedNCT04957290Written as NOX66
- A Dose Escalation and Dose Expansion Study of NOX66 in the Treatment of COVID-19CompletedPhase 1Noxopharm LimitedNCT04555213Written as NOX66
- Safety, PK and Efficacy of NOX66 as a Monotherapy and Combined With Carboplatin in Refractory Solid TumoursCompletedPhase 1/2Noxopharm LimitedNCT02941523Written as NOX66
- A Study of Safety and Tolerability of NOX66 in Healthy VolunteersWithdrawnPhase 1Noxopharm LimitedNCT03780465Written as NOX66 (A)